Subscribe To
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Buckle up. intc stock still faces a rocky road ahead
Shares in chip maker Intel (NASDAQ: INTC ) were hammered throughout 2022, with INTC stock staying on a downward trajectory during the first two mont...
April 16, 2023, 11:30 am
Inflation's last stand
U.S. equity markets finished broadly higher this past week after a critical slate of inflation data provided further evidence of a definitive cool-dow...
April 16, 2023, 9:00 am
Xrp under pressure as investors digest the latest sec v ripple filings
After a bearish Saturday, XRP was back in negative territory this morning. Regulatory risk and law maker scrutiny remain broader market headwinds. The...
April 16, 2023, 4:03 am
Marketwatch: slowdown in lending could help fed bring down inflation while maintaining a strong job market, yellen says
The U.S. economy may still achieve a soft landing as a slowdown in lending does some of the Federal Reserve’s work in bringing down inflation, despi...
April 15, 2023, 6:13 pm
Aud/usd forecast: aussie jumps to test 0.6800, technicals favor a break above
The AUD/USD rose sharply on Thursday, after accelerating to the upside during the American session on the back of risk appetite and broad-based Dollar...
April 15, 2023, 12:44 pm
Csx boss: railroads' efficiency model wasn't implemented properly
New CEO Joe Hinrichs says railroads' use of the vaunted precision-scheduling model hasn't put enough focus on employees and customers....
April 15, 2023, 10:00 am
Bitcoin thief once worth $3.4 billion gets year in prison
A Georgia man who stole more than 50,000 Bitcoin from the Silk road drug-trafficking site before his ca...
April 15, 2023, 7:29 am
China march new home prices rise at fastest pace in 21 months
BEIJING (Reuters) -China’s new home prices rose in March at the fastest pace in 21 months, official data showed on Saturday, as continued government...
April 15, 2023, 2:01 am
Bitcoin thief once worth $3.4 billion gets a year in prison
A Georgia man who stole more than 50,000 Bitcoin from the Silk road drug-trafficking site before his ca...
April 14, 2023, 10:14 pm
Acme united to release first quarter 2023 financial results on april 21, 2023
SHELTON, Conn., April 14, 2023 (GLOBE NEWSWIRE) — Acme United Corporation (NYSE American: ACU) will release its financial results for the First Quar...
April 14, 2023, 8:15 pm